Key result
Inflammatory lipids interact with chemokine pathways to drive chronic inflammation in atherosclerosis.
Answers are grounded in this paper and cite their sources.
Chemokines are a diverse group of molecules with important implications for the development of solid tissues and normal function of the immune system. However, change of the conditions for such a complex system can have important and dangerous consequences leading to diseases. The specific implications of the various chemokines in diseases have been elucidated in the last few years, prompting hope of manipulating this system for therapy or prevention of diseases. On the other hand, inflammatory lipids are biologically active molecules with crucial impacts on the function of various cell types, including immune cells in health and disease. Here, we describe how these lipids affect the chemokine system and how they interact with chemokines to shape chronic inflammation in the case of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Rolin et al. (2014) conducted a review in Atherosclerosis. Chemokines, chemokine receptors, and inflammatory lipids was evaluated. Inflammatory lipids interact with chemokines and their receptors to modulate immune cell function and shape chronic inflammation in atherosclerosis (narrative review; no quantitative data reported).
Synapse has enriched 5 related papers. Consider them for comparative context: